MIRA Pharmaceuticals, Inc.
Developing the next generation of oral ketamine and pharmaceutical marijuana analogs to treat neurologic neuropsychiatric disorders
Improved Therapies with Potential Results
With small changes, MIRA's technology focuses on big effects that have the potential to redefine therapeutic outcomes, opening up new markets for indications and patients.
Email Alerts
Sign up today and receive company updates straight to your inbox.